Smith & Nephew (SNN) Non-Current Assets (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Non-Current Assets of $6.4 billion for Q4 2025, up 7.1% year-on-year from $5.9 billion in Q4 2024, and up 7.1% on a QoQ basis from $5.9 billion in Q4 2024.
Smith & Nephew (SNN) Non-Current Assets (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Non-Current Assets for 17 consecutive years, with $6.4 billion the latest figure, recorded in Q4 2025.
- Quarterly Non-Current Assets rose 7.1% year-over-year to $6.4 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.4 billion (up 170.03% YoY) and the FY2025 annual result came in at $6.4 billion, up 7.1% from the prior year.
- Non-Current Assets rose to $6.4 billion in Q4 2025 per SNN's latest filing, from $5.9 billion in the prior quarter.
- Over the last five years, Non-Current Assets for SNN reached as high as $6.4 billion in Q4 2025 and fell as low as -$4.4 billion in Q4 2021.
- A 5-year average of $5.4 million and a median of -$3.8 billion in 2022 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2023 — Non-Current Assets declined 4.37% — and 2024, when it jumped 247.88%.
- Year by year, Non-Current Assets stood at -$4.4 billion in 2021, then advanced by 12.72% to -$3.8 billion in 2022, then slipped by 4.37% to -$4.0 billion in 2023, then soared by 247.88% to $5.9 billion in 2024, then gained by 7.1% to $6.4 billion in 2025.
- According to Business Quant data, Non-Current Assets over the past three periods registered $6.4 billion, $5.9 billion, and -$4.0 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 8.34 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.35 Bn |
| Dec 31, 2024 | 5.93 Bn |
| Dec 31, 2023 | -4.01 Bn |
| Dec 31, 2022 | -3.84 Bn |
| Dec 31, 2021 | -4.40 Bn |
| Dec 31, 2020 | -4.66 Bn |
| Dec 31, 2019 | -3.21 Bn |
| Dec 31, 2018 | -3.04 Bn |
| Dec 31, 2017 | -2.71 Bn |
| Dec 31, 2016 | 4.82 Bn |
| Dec 31, 2015 | 4.69 Bn |
| Jun 30, 2015 | 4.78 Bn |
| Dec 31, 2014 | 4.87 Bn |
| Jun 28, 2014 | 5.21 Bn |
| Mar 31, 2014 | 3.55 Bn |
| Dec 31, 2013 | 3.56 Bn |
| Sep 28, 2013 | 3.40 Bn |
| Mar 31, 2013 | 3.40 Bn |
| Dec 31, 2012 | 3.50 Bn |
| Sep 29, 2012 | 2.71 Bn |